pattern

Personalized health monitoring, Anytime, Anywhere

Anasens is developing a new portable device for recurrent testing, useful for illicit drug detection, therapeutic drug monitoring (TDM) and chronic disease management.

arrow
Problem

The need for lab testing at home or where it matters

Every day, thousands of people spend hours traveling and waiting for the routine blood tests required for the monitoring of their chronic disease. What if it was possible to avoid such troubles to obtain your test results? Even better, what if these results were shared in real-time with your healthcare team?

The need for lab testing at home or where it matters-->

More than 70% of medical decisions rely on laboratory tests

Personalized health monitoring, Anytime, Anywhere

Current home technologies

Lateral Flow*
Lateral Flow*

  • -“Yes” or “No” answer: not quantitative!
  • – A bit long and complicated (> 10 min)
  • – Not digital, not connected

* e.g. Covid and pregnancy tests.
Glucometers
Glucometers

Simple, quantitative, connected. But technology that only works to detect glucose or lactate (singlePlex)

Solution

Anasens brings the robustness of centralized laboratories in the palm of your hand

Anasens brings the robustness of centralized laboratories in the palm of your hand

Nanotechnology, artificial intelligence, and connectivity are poised to disrupt personal medical technologies. The ability to quickly measure molecules in the body (blood, saliva, urine) and share this information will create a medical and commercial revolution. Anasens increases accessibility to precision medicine by offering lab-quality testing that can be done when and where it matters.

A medical and commercial revolution

A medical and commercial revolution

Benefits:

Quick and simple:

Works directly into a drop of saliva or blood in one minute

Affordable:

Electrochemical sensing is inexpensive

Quantitative/digital:

Precise concentration measurement without user interpretation

Multiplexable and adaptable:

Can detect up to six molecules/markers simultaneously

Universal and adaptable:

Can detect almost any type of molecule/marker

A seasoned team combining industry expertise and technical rigor
About Us

A seasoned team combining industry expertise and technical rigor

Built around experienced talent capable of uncovering solutions where others see challenges. 
At Anasens, individual experience fuels collective intelligence to develop high-impact solutions.

Board of Directors:

Eric Dupont
Eric Dupont

Chairman

Louis-François Hogue

Administrator

Veronique Bougie

Administrator

Alexis Vallée-Belisle

Administrator

Pierre Fitzgibbon
Pierre Fitzgibbon

Administrator

Partners

Canada research chairs Universite de Montréal Economie et Innovation Québec NSERC CRSNG Canada foundation of Innovation Institut Transmedtech Grand challenges Canada Centech Biron Flux continu foncer Proteo
pattern